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Abstract. The hck gene is member of src family of non-receptor type tyrosine kinases. 
Here we report the nucleotide sequence of the rat hck eDNA of 1.94 kb. The nuclcotide 
sequence shows an open reading frame coding for a polypeptide of 503 amino acids. A 
vector expressing a fusion protein of glutathione-S-transferase with 82 amino acids of the 
N-terminal region of hck (from amino acids 32 to 113) was constructed, Using this 
bacterially expressed fusion protein antibodies were prepared which recognize the cellular 
hck gene product. These antibodies identified, by immunoblotting, two polypeptides of 56 
and 59 kDa in rat spleen where hck transcripts are present at high level. Immunoprecipitated 
hck polypeptides were enzymatically active and were autophosphorylated in the presence 
of ATP and Mg2+. 1mmunoprecipitated hck could phosphorylate exogenous substrates. 
Treatment of immunoprecipitated hck by a purified protein tyrosine phosphatase decreased 
its enzymatic acitivity. Our results suggest that the enzymatic activity of hck tyrosine kinase 
is regulated by phosphorylation and dephosphorylation. 
 
Keywords. hck; protein tyrosine kinase; enzyme regulation; nucleotide sequence; auto-
phosphorylation. 
 
1. Introduction 
 
Protein tyrosine kinases have been implicated to be key regulatory molecules in 
the signal transduction pathways controlling many vital cellular processes. These 
protein tyrosine kinases have been broadly classified into two classes (Swarup et 
al 1984; Hunter and Cooper 1985). The transmembrane receptor tyrosine kinases 
have direct involvement in signal transduction pathways (Ulrich and Schlessinger 
1990). The non-receptor kinases are intracellular proteins which lack both trans-
membrane and extracellular domains, but are capable of membrane association 
(Hunter and Cooper 1985; Sreevastava 1990; Bolen 1993). The members of the 
src gene family src, lck, lyn, fyn, yes, fgr and blk share common structural 
features and many of them are expressed in various hematopoietic cells (Perlmutter 
et al 1988; Eiseman and Bolen 1990). Recent studies have shown that fyn, lyn 
and lck are associated with cytoplasmic domains of different cell surface receptors 
(Rudd et al 1988; Veillette et al 1988; Samelson et al 1990; Yamanashi et al 
1991), suggesting, therefore, that the members of src gene family might play 
important roles in signal transduction. Strong evidence in favour of this comes 
from the studies demonstrating direct physical and functional association of fyn 
tyrosine kinase with the antigen receptors of T cells (Samelson et al 1990). 
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We have earlier isolated cDNA clones coding for hck tyrosine kinase from a 
rat spleen cDNA library (Rema and Swarup 1990). Here we report the complete 
nucleotide sequence of rat hck cDNA. The polypeptide products of the rat hck 
gene were identified by preparing antibodies using a fusion protein of hck with 
glutathione-S-transferase (GST), made in Escherichia coli, as antigen. Using these 
antibodies we have characterized the enzymatic properties of immunoprecipitated 
hck protein; our results suggest that its kinase activity is regulated by phosphorylation 
and dephosphorylation. 
 
2. Materials and methods 
 
2.1 Analysis of RNA 
 
Total RNA was isolated from various tissues using the method of Chomczynski 
and Sacchi (1987). mRNA was purified by oligo dT cellulose (Pharmacia) column 
chromatography. Total RNA (10 µg) or mRNA (5·µg) was separated on 1% 
agarose gel containing 2·2 M formaldehyde and transferred to nitrocellulose 
membrane. To ensure that equal amounts of RNA were present, 0·5 µg of 
ethidium bromide was added to the (25 µl) samples prior to loading, to visualize 
RNA after the gel was run. Hybridization was done at 50°C as described 
previously (Swarup et al 1991). The blots were washed with 0·2 × SSPE + 
0·1% SDS at 60°C and kept for autoradiography at - 70°C. The hck probe was 
labelled by nick translation. 
 
2.2 Isolation of rat hck cDNA clones and sequence analysis 
 
Rat hck cDNA clones were isolated from a rat spleen cDNA library (Rema and 
Swarup 1990). Complete nucleotide sequence of the largest clone Ll15 (which 
contains 1940 nucleotides) was determined by sequencing both strands of DNA 
using dideoxy chain termination method (Sanger et al 1977) as modified for double 
stranded DNA by Chen and Seeburg (1985). Smaller clones of hck and various 
restriction fragments of the large clone L115 were subcloned into pUC 19 for 
sequence analysis. This nucleotide sequence has been deposited with EMBL data 
bank (accession number X 62345). Standard molecular cloning experiments such 
as ligations, transformation etc., were carried out as described by Sambrook et al 
(1989). 
 
2.3 Preparation of tissue samples 
 
Soluble and particulate fractions from various tissues were prepared as described 
previously (Swarup and Subrahmanyam 1989). Normal macrophages were collected 
from the rat by peritoneal lavage, by injecting l0 ml PBS. The cells were then 
washed with PBS and used for further experiments. 
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2.4 Preparation of hck antibodies 
 
A 246 bp BamHI-HincII fragment (amino acids 32 to l13) from the 5' coding 
region of the rat hck cDNA was ligated with BamHI and SmaI digested pGEX-1 
expression vector (Smith and Johnson 1988). The resulting construct, pGEX-hck, 
expressed a fusion protein with GST carrying hck sequences at the C-terminal end. 
This fusion protein band of 35 kDa was electroeluted from polyacrylamide gels and 
used to inject several Balb/c mice with complete Freund's adjuvant. Two further 
injections were given with Freund's incomplete adjuvant at 15 day intervals and 
blood was collected 4 days after the 3rd injection. Antibody titres were monitored 
by immunodiffusion and immunoblotting. 
 
2.5 Production of hck monoclonal antibodies 
 
Splenocytes were collected from a mouse showing high hck antibody titre after 
boosting with the bacterially expressed GST-hck fusion protein intraperitoneally. 
These splenocytes were fused with Sp2/0 myeloma cells by using polyethylene 
glycol method. Hybrid cells were dispersed in HAT-IMDa over a layer of mouse 
peritoneal macrophage feeder cells (Fazekas de St. Groth and Scheidegger 1980). 
Supernatants from HAT resistant colonies were checked for antibody secretion by 
enzyme linked immuno filtration assay (ELIFA) and Western blotting and the 
positive clones propagated. Colonies giving a good positive reaction were cloned 
by limiting dilution. The hybridoma cell lines were maintained in IMDM supplemented 
with 10% FCS and antibiotics. 
 
2.6 Immunoblotting 
 
Proteins fractionated by SDS-PAGE were transferred electrophoretically to 
Immobilon-P membranes. The membranes were blocked using 1% horse serum in 
TBST-gelatin (10 mM Tris-CI, pH 8·0, 150 ma NaCl, 0·05% Tween E0 and 0·2% 
gelatin) for 1 h. The blots were incubated with either polyclonal antibody diluted 
1 : 1000 or hybridoma supernatant diluted 1 : 10 for 2 h. After washing for 2 h, the 
blots were incubated with alkaline phosphatase conjugated anti mouse IgG for 1 
h. After washing, immuno reactive bands were visualized using nitroblue tetrazolium 
and 5-bromo-4-chloro-3-indolyl phosphate. 
For competition experiments 10 µg of purified GST-hck fusion protein of 
35 kDa was incubated at room temperature for 30 min with 5 µI of antiserum in 
a volume of 500 µI and then used as primary antibody after diluting to 5 ml in 
TBST. 
 
2.7 Immunoprecipitation, kinase assay and phosphates treatment 
 
Particulate fraction (0.l mg protein) of rat spleen was extracted with 0·5 ml of IP 
buffer (1 × IP buffer contains 150 mM NaCI, 1% Triton, 0·5% deoxycholate, 2 mM 
EDTA, E mM PMSF, E µg/ml soyabean trypsin inhibitor and 2 µg/ml leupeptin) on 
ice and centrifuged at 15,000 g for 20 min. Incubation with antibody or control 
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medium was carried out for 1 h at 4°C by gentle mixing. Preswollen protein 
A-sepharose beads were added and further mixed for 30 min. The beads were 
centrifuged and washed 5 times with IP buffer. 
Phosphorylation of the immunoprecipitated hck was carried out in 25 mM Tris-CI, 
pH 7·5, 10 mM MgC12 1 mM DTT, 2 mM PMSF, and protease inhibitors (leupeptin, 
antipain, soyabean trypsin inhibitor) at 2 µg/ml, 1 µM  [γ-32P]ATP (specific activity 
5 × 104 cpm/pmol) in a total volume of 0.05 ml. After incubating at 30°C for 10 
min the reaction was stopped by adding 0·05 ml of 2 × SDS sample buffer and 
boiled for 3 min. Exogenous substrate, 10 µg of poly (Glu4, Tyr1) was included 
wherever indicated. Treatment with phosphatase was carried out at 30°C for 10 
min in the same buffer but without MgC12 or ATP. After phosphatase treatment 
the kinase assay was started by adding ATP, MgC12 and sodium orthovanadate 
(100 µM). The phosphatase used was a protein-tyrosine phosphatase expressed in 
E. coil (see below) and was added at 0·5 µg (2-3 µl) per assay. 
 
2.8 Purification of a protein tyrosine phosphatase made in E. coli 
 
A protein tyrosine phosphatase, PTP-S, has been expressed in E. colic at high level 
by constructing an expression vector (Radha et al 1993). This phosphatase was 
extracted from E. coli cells carrying the expression vector as described previously 
(Radha et al 1993). This extract was applied on a DEAE-Sephacel column, washed 
and the phosphatase was eluted with 0.1 M NaCl in the column buffer (25 mM 
Tris-C1, pH 7.l, 1 mM EDTA, 0.025% mercaptoethanol, 10% glycerol, 0.1% Triton 
X-100). Column fractions were assayed for tyrosine phosphatase activity using 
32P-labelled poly (Glu4, Tyr1) as substrate as described by Swarup and Subrahmanyam 
(1989). The purified enzyme was stored in 50% glycerol made in column buffer. 
This storage buffer was used as control buffer for phosphatase treatment experiments. 
 
3. Results 
 
3.1 Nucleotide sequence of rat hck 
 
The rat hck cDNA clones were isolated by screening a spleen cDNA library (Rema 
and Swarup, 1990). The nucleotide sequence of the largest clone (1.94 kb) showed 
an open reading frame coding for a polypeptide of 503 amino acids beginning 
after 212 nucleotides at the 5' end (figure 1). Figure 2 shows a comparison of 
first 80 amino acids of human, mouse and rat hck gene products starting from the 
initiator ATG codon, which is numbered + 1. Human and mouse hck sequences 
are taken from published papers (Quintrell et al 1987; Ziegler et al 1987; Holtzman 
et al 1987). Translation of mouse hck can also initiate from a CTG codon located 
21 codons 5' of the ATG codon (Lock et al 1991). This CTG codon, beginning 
at nucleotide 150 (figure l) is also conserved in rat hck sequence and is numbered 
–21 in figure 2. The rat and mouse hck proteins show 97% identity (16 substitutions) 
whereas rat and human hck and proteins show 89% identity (53 substitutions and 
2 single amino acid deletions in rat hck). Most of the differences (11 out of 16) 
in amino acids between mouse and rat hck protein are located within the first 100 
amino acids. This is also the case with human protein in which 29 out of 55 
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Figure 1 Nucleocide and deduced amino acid sequence of rat lick cDNA isolated from 
spleen cDNA library. 
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Figure 2 Comparison off amino terminal 100 amino acids off the rat, mouse and human 
hck. The initiator ATG codon is numbered as +1, Human and mouse sequences are taken 
from published papers (Quintrell et al 1987; Ziegler el al 1987; Holtzman et al 1987). 
 
differences are located within the first 100 amino acids (figure 2). This suggests 
that the variability occurs mainly in the N-terminal region of the protein. There 
are three cysteine residues near the amino terminal end at positions –15, –10 and 
+3 which are conserved in rat, mouse and human (figure 2). 
The rat hck protein shows a highly conserved tyrosine kinase domain beginning 
at amino acid 230. The tyrosine kinases of src family share conserved SH2 and 
SH3 domains (src homology domains 2 and 3, respectively). The SH2 (amino acids 
109-229) and SH3 domains (amino acids 6l–l08) are also present in the rat hck 
in the N-terminal half of the protein. Amino acids 1-60 do not show any significant 
homology to any known protein and this region is therefore known as unique 
region. Two conserved Tyr residues, Tyr 388 and Tyr 499 are homologous to the 
autophosphorylation and negative regulatory phosphorylation sites, respectively, of 
the src kinase. 
 
3.2 Expression of hck transcripts 
 
We analysed the expression of hck transcripts in rat thymus, spleen and some other 
tissues, Northern hybridization was carried out with RNA from rat tissues, using 
a 550 base pair EcoRI-HinclI fragment from the 5' end of the rat hck cDNA clone, 
L115. A major transcript of 2·2 kb was seen in the spleen. Another faint band of 
larger size was also observed. On longer exposure of the blot similar size transcripts 
were detected in thymus (figure 3), at very low level. hck transcripts could not 
be detected in brain and liver. 
 
3.3 Identification of hck gene product 
 
In order to identify the protein product coded by hck, antibodies were prepared 
using a fusion protein of GST and hck (amino acids 32 to 113) as immunogen. 
Construction of the vector pGEX-hck (figure 4) which expresses the 35 kDa GST-hck 
fusion protein in bacteria under the control of the inducible tac promoter is 
described in §E. The polyclonal antibodies raised in mice and the monoclonal 
hck tyrosine kinase regulation 123 
 
 
 
Figure 3. Analysis of hck transcripts from different rat tissues. Poly (A)+ RNA (5 µg) 
from indicated tissues was hybridized to 5' specific fragment of the rat hck cDNA as 
described in §2, The same blot was reprobed with actin (lower panel). The actin probe used 
was ß-actin which seems to be expressed al different levels in various tissues. However, an 
actin blot shows that the absence of hck transcripts in these tissues is not due to degradation 
of RNA. 
 
antibody recognized the GST-hck fusion protein but not the GST itself by immuno-
blotting. These polyclonal as well as a monoclonal antibody identified two poly-
peptides of 59 and 56 kDa by immunoblotting in the particulate fraction of rat 
spleen (figure 5). When antibodies were preincubated with GST-hck fusion protein 
prior to immunoblotting, these two bands of 59 and 56 kDa were not observed 
suggesting that these polypeptides are not non-specifically precipitated. 
 
3.4 Kinase activity of hck protein 
 
Many protein tyrosine kinases can autophosphorylate upon incubation with ATP 
and divalent cations. The protein kinase activity of hck proteins was examined in 
the immunoprecipitate. For this purpose extracts were prepared from rat peritoneal 
macrophages or the particulate fraction of spleen and immunoprecipitation was 
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Figure 4. Restriction map of rat hck cDNA and schematic drawing of the vector pGEX-hck 
which expresses GST-hck fusion protein. The restriction sites are abbreviated. E, EcoRI; 
B, BamHI (at nucleotides 173, 305, 1505); S, Smal (358, 626); H, HincII (551). The 
numbers such as 32 and 113 are amino acids of rat hck as in figure 1. SH2 and SH3 
are sic homology domains 2 and 3, respectively. 
 
 
Figure 5. Identification of hck gene product by Western blotting. Particulate fraction from 
rat spleen (0·1 mg) was fractionated by SDS-PAGE on a 10% gel and analysed by Western 
blotting using polyclonal (lane I) or monoclonal (lane 2) hck antibody. 
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carried out using polyclonal antibodies and protein A-Sepharose as described under 
§2. The immunoprecipitate was incubated with [γ-32P]ATP and Mg2+ and the resultant 
phosphorylated proteins were analysed by SDS-PAGE followed by autoradiography. 
Two polypeptides of 59 and 56 kDa were phosphorylated in the hck immunoprecipitate 
(figure 6, lanes 2, 3). This phosphorylation was alkali-stable (data not shown). The 
immunoprecipitated hck could phosphorylate poly (Glu4, Tyr1), a synthetic substrate 
for tyrosine kinases (figure 7, lane 1), but not BSA. When antibodies were 
preincubated with GST-hck fusion protein prior to immunoprecipitation, the 59 or 
56 kDa phosphorylated bands were not observed (figure 6, lanes 1, 4). 
 
 
Figure 6. Protein kinase activity of hck gene product in the immunoprecipitate. Rat 
peritoneal macrophages (lanes 1, 2) or spleen particulate fraction (lanes 3, 4) were extracted 
and the extracts were subjected to immunoprecipitation and kinase assays as described in 
§2. The antibody was competed with GST-hck fusion protein (lanes 1, 4) for determining 
specificity. The samples were analysed by SDS-PAGE on a 12% gel followed by 
autoradiography. 
 
3.5 Regulation of kinase activity by phosphorylation 
 
Activity of some protein tyrosine kinases is regulated by autophosphorylation 
(Swarup and Radha, 1992). In order to test this possibility, immunoprecipitated hck 
was preincubated with ATP and Mg2+ followed by the addition of exogenous 
substrate; there was no increase in the tyrosine kinase activity of hck. This suggested 
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Figure 7. Effect of phosphatase treatment on the kinase activity of hck, Immunoprecipitated 
hck was incubated with control buffer (lane I), purified protein tyrosine phosphatase (lane 
2) or phosphatase plus 100 µM sodium orthovanadate (lane 3) for [0 min at 30°C. The 
kinase reaction was then started as described under §2. The sample in lane 4 contained 
phosphatase during kinase reaction only. Orthovanadate was always present during kinose 
reaction so as to prevent dephosphorylation. The arrow indicates the position of phosphatase 
(Mr 47 kDa). 
 
that either hck is not regulated by autophosphorylation or it is already in an 
activated, phosphorylated state. In case hck was already in an activated, phosphorylated 
state, dephosphorylation by a tyrosine phosphatase is expected to decrease its kinase 
activity. Therefore immunoprecipitated hck was treated with a purified protein-tyrosine 
phosphatase prior to kinase assay with poly (Glu4, Tyr1) as substrate; there was 
nearly complete loss of kinase activity of hck (figure 7, lane 2). This loss of kinase 
activity upon treatment with protein tyrosine phosphatase was prevented substantially 
if orthovanadate, a known inhibitor of this and other protein tyrosine phosphatases 
(Swarup et al 1982; Swarup and Subrahmanyam l989; Radha et al 1993) was 
included during phosphatase treatment (figure 7, lane 3). These observations suggest 
that phosphatase treatment inactivates hck by dephosphorylation. Therefore, the hck 
protein is in a phosphorylated, active state, which becomes less active or inactive 
by dephosphorylation. During incubation of hck with phosphatase in the presence 
of vanadate, the phosphatase was phosphorylated by hck (figure 7, lane 3). When 
phosphatase was added during the kinase assay, there was no effect on enzyme 
activity of hck (figure 7, lane 4) suggesting thereby that the phosphatase does not 
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interfere with the kinase activity in presence of vanadate. Because the PTP was 
added with vanadate, vanadate was always present during kinase assay. A labelled 
PTP band should be present in lane 4 but since poly (Glu, Tyr) is phosphorylated 
and gives a smear in that region the band cannot be seen. On shorter exposure 
one can see a PTP band but not as clearly as in lane 3. The phosphatase treated, 
inactive hck could be reactivated partially upon incubation with ATP (figure not 
shown). Incomplete reactivation may be due to phosphorylation of phosphatase by 
hck which may compete for autophosphorylation reaction. 
 
4. Discussion 
 
The nucleotide sequence of rat hck shows an open reading frame beginning with 
an ATG codon, coding for a polypeptide of 503 amino acids. In mouse hck 
translation can also initiate from an upstream CTG codon which was found to be 
conserved in the rat hck sequence also. This would give rise to a polypeptide of 
524 amino acids. Identification of the hck gene product with antibodies showed 
two polypeptides of 59 and 56 kDa which are similar in size to mouse hck proteins. 
These polypeptides are enzymatically active, as shown by phosphorylation of 
exogeneous substrate and also by autophosphorylation. 
A comparison of rat hck protein sequence in the N-terminal region with the 
mouse and human sequences shows that 3 cysteines are conserved at positions –15, 
–10 and +3. The 56 kDa product of hck will have only one conserved cysteine. 
Two cysteine residues in the amino terminal region of lck are known to play an 
important role in its interaction with CD4 and CD8 glycoproteins in T cells (Shaw 
et al 1989; Turner et al l990). Whether hck polypeptides interact with any cell 
surface proteins is not known. Another important point that emerges from sequence 
comparison (figure 2) is that although most of the differences are in the N-terminal 
100 amino acids, the first l4 amino acids are identical in all the 3 species in the 
59 kDa form of hck. This conservation suggests an important role for these 14
amino acids in the hck protein. 
The protein kinase activity of hck appears to be regulated by phosphorylation. 
Treatment with phosphatase decreases kinase activity of hck, which suggests that 
in the immunoprecipitate, hck is in the phosphorylated, active state. The effect of 
phosphatase on kinase activity is due to dephosphorylation; this is suggested by
the observation that the phosphatase inhibitor vanadate largely prevented inactivation 
of the kinase by phosphatase. 
Regulation of protein kinase activity of low molecular weight tyrosine kinases 
by phosphorylation is known for a few kinases (Swarup and Radha 1992). We had 
previously shown that the kinase activity of TK-I, a tyrosine kinase isolated from 
|rat spleen, is regulated by autophosphorylation at tyrosine (Swarup and Subrahmanyam 
1985a, b l989); dephosphorylation by a phosphatase inactivates this kinase (Swarup 
and Subrahmanyam 1989). This kinase could be isolated in the active state by 
including vanadate during purification; this preparation could not be activated further 
by incubation with ATP since it was already in the phosphorylated, active state 
(Swarup and Subrahmanyam l985, 1988, 1989). Another kinase isolated from bovine 
spleen was in the active state and could be inactivated by dephosphorylation (Kong 
et al 1988). The hck kinase activity seems to be regulated by phosphorylation in 
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the same manner as that of TK-I or the kinases from bovine spleen and lung 
(Kong et al 1988; Sreevastava and Chiasson 1988). 
Regulation of protein kinase activity by phosphorylation is a very complex process 
which has been analysed in great detail in the case of c-src kinase (Hunter 1987). 
Phosphorylation at Tyr 416, which is also the in vitro autophosphorylation site, 
increases the kinase activity of c-src whereas phosphorylation at Tyr 527 inhibits 
its activity. When both the sites are phosphorylated the kinase activity is inhibited. 
Phosphorylation at Tyr 527, which is carried out by a tyrosine kinase named csk, 
inhibits kinase activity only when both SH2 and SH3 domains are intact. Deletion 
of SH2 or SH3 domains, or certain point mutations in these regions, affect inhibition 
of src kinase activity by phosphorylation at Tyr 527 (Superti-Furga et al 1993). 
Therefore, interaction of SH2 and SH3 domains with phosphorylated Tyr plays an 
important role in regulating kinase activity (Pawson and Gish 1992; Superti-Furga 
et al 1993). In addition, SH2 and SH3 domains are also involved in the interaction 
of these kinases with other proteins (Pawson and Gish 1992). The hck sequence 
shows conserved potential phosphorylation sites at Tyr 388 (homologous to Tyr 416 
of c-src) and Tyr 499 (homologous to Tyr 527 of c-src). Which sites are phos-
phorylated in hck in vitro and in vivo are not known at present, Our results suggest 
that dephosphorylation of immunoprecipitated hck inhibits kinase activity, implying 
thereby that the hck protein is phosphorylated in vivo at a positive regulatory site. 
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